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Toward a Better Understanding of...

The Role of Notch Signaling on Heart Rate
and Atrial Conduction Velocity
Somya Bhatnagar
Mentor: Stacey Rentschler
Heart disease is the leading cause of death worldwide and can result in arrhythmias,
or dysregulation in the electrical activation of the heart. Sick Sinus Syndrome (SSS) is
characterized by sinus bradycardia (slowed heart rate, HR), slowed conduction through
atrial myocardium, and can predispose to the development of atrial fibrillation. A
developmental signaling pathway, Notch, regulates cellular identity through differentiation
of cardiomyocytes (CMs) into cardiac conduction system-like cells. Previous data
show that Notch electrically remodels the right atrium, causing slowed conduction
velocity (CV) and hallmarks of SSS including sinus pauses, sinus bradycardia and a
predisposition to atrial fibrillation. However, the molecular mechanisms behind these
phenotypes are not known. We hypothesized that Notch activation produces slowed CV
through downregulation of major cardiac voltage-gated sodium channel (NaV1.5) and
atrial gap junction (Connexin40, Cx40). A “Tet-On” doxycycline-activated system using
transgenic adult mice was used to activate Notch specifically in CMs. We assayed various
determinants of CV, including fibrosis, cellular hypertrophy, and Na+ channel and gap
junction expression. Trichrome stain and hydroxyproline assay indicated normal levels
of non-conductive fibroblasts. To determine whether Notch activation is associated with
pathophysiological hypertrophy, I quantified cell area using immunohistochemistry
and found no difference in Notch activated hearts when compared with controls.
Furthermore, immunohistochemistry indicated no gross changes in NaV1.5 or Cx40
expression within the atrial myocardium. However, localization of NaV1.5 and Cx40
within the plasma membranes of CMs, as well as post-translational modifications that
may result in slowed conduction velocity are yet to be analyzed. Future studies will
determine whether Notch-induced slowed HR is due to autonomous changes within
the pace-making sinus node (SAN) region or non-autonomous changes within the
atrial myocardium. Notch will be activated specifically in the SAN of the adult mouse
heart using an HCN4-creER tamoxifen-inducible system and HR will be evaluated using
electrocardiograms.
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